4934 Stock Overview
Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order, wholesale, and retail of cosmetics and health foods in Japan.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Premier Anti-Aging Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥896.00 |
52 Week High | JP¥1,957.00 |
52 Week Low | JP¥844.00 |
Beta | 0.90 |
1 Month Change | -2.93% |
3 Month Change | -11.37% |
1 Year Change | -33.78% |
3 Year Change | -92.74% |
5 Year Change | n/a |
Change since IPO | -82.97% |
Recent News & Updates
Shareholder Returns
4934 | JP Personal Products | JP Market | |
---|---|---|---|
7D | -2.2% | -2.1% | 1.7% |
1Y | -33.8% | -15.3% | 37.6% |
Return vs Industry: 4934 underperformed the JP Personal Products industry which returned -15.3% over the past year.
Return vs Market: 4934 underperformed the JP Market which returned 37.6% over the past year.
Price Volatility
4934 volatility | |
---|---|
4934 Average Weekly Movement | 5.2% |
Personal Products Industry Average Movement | 3.7% |
Market Average Movement | 3.9% |
10% most volatile stocks in JP Market | 8.4% |
10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 4934 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4934's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 252 | Kiyoshi Matsuura | https://www.p-antiaging.co.jp |
Premier Anti-Aging Co., Ltd. engages in the planning, development, import, export, mail order, wholesale, and retail of cosmetics and health foods in Japan. It offers its products under the DUO, CANADEL, Immuno, Sitrana, and Clayence brands. The company was incorporated in 2009 and is headquartered in Tokyo, Japan.
Premier Anti-Aging Co., Ltd. Fundamentals Summary
4934 fundamental statistics | |
---|---|
Market cap | JP¥7.84b |
Earnings (TTM) | -JP¥2.39b |
Revenue (TTM) | JP¥22.79b |
0.3x
P/S Ratio-3.3x
P/E RatioIs 4934 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4934 income statement (TTM) | |
---|---|
Revenue | JP¥22.79b |
Cost of Revenue | JP¥6.23b |
Gross Profit | JP¥16.56b |
Other Expenses | JP¥18.96b |
Earnings | -JP¥2.39b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -274.30 |
Gross Margin | 72.67% |
Net Profit Margin | -10.50% |
Debt/Equity Ratio | 37.7% |
How did 4934 perform over the long term?
See historical performance and comparison